These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 10580130)
1. Pathways of O-glycan biosynthesis in cancer cells. Brockhausen I Biochim Biophys Acta; 1999 Dec; 1473(1):67-95. PubMed ID: 10580130 [TBL] [Abstract][Full Text] [Related]
2. O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. Vavasseur F; Dole K; Yang J; Matta KL; Myerscough N; Corfield A; Paraskeva C; Brockhausen I Eur J Biochem; 1994 Jun; 222(2):415-24. PubMed ID: 8020479 [TBL] [Abstract][Full Text] [Related]
3. The pattern of glycosyl- and sulfotransferase activities in cancer cell lines: a predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans. Chandrasekaran EV; Xue J; Neelamegham S; Matta KL Carbohydr Res; 2006 Jun; 341(8):983-94. PubMed ID: 16545347 [TBL] [Abstract][Full Text] [Related]
4. Alterations of O-glycan biosynthesis in human colon cancer tissues. Yang JM; Byrd JC; Siddiki BB; Chung YS; Okuno M; Sowa M; Kim YS; Matta KL; Brockhausen I Glycobiology; 1994 Dec; 4(6):873-84. PubMed ID: 7734850 [TBL] [Abstract][Full Text] [Related]
5. Glycodynamics of mucin biosynthesis in gastrointestinal tumor cells. Brockhausen I Adv Exp Med Biol; 2003; 535():163-88. PubMed ID: 14714895 [TBL] [Abstract][Full Text] [Related]
6. Glycoproteins and their relationship to human disease. Brockhausen I; Schutzbach J; Kuhns W Acta Anat (Basel); 1998; 161(1-4):36-78. PubMed ID: 9780351 [TBL] [Abstract][Full Text] [Related]
7. Access to peptide regions of a surface mucin (MUC1) is reduced by sialic acids. Ho JJ; Cheng S; Kim YS Biochem Biophys Res Commun; 1995 May; 210(3):866-73. PubMed ID: 7539263 [TBL] [Abstract][Full Text] [Related]
8. Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers. Miyamoto K; Asada K; Fukutomi T; Okochi E; Yagi Y; Hasegawa T; Asahara T; Sugimura T; Ushijima T Oncogene; 2003 Jan; 22(2):274-80. PubMed ID: 12527896 [TBL] [Abstract][Full Text] [Related]
9. Lewis glyco-epitopes: structure, biosynthesis, and functions. Chen HL Adv Exp Med Biol; 2011; 705():53-80. PubMed ID: 21618104 [No Abstract] [Full Text] [Related]
10. Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation. Ghaderi D; Zhang M; Hurtado-Ziola N; Varki A Biotechnol Genet Eng Rev; 2012; 28():147-75. PubMed ID: 22616486 [TBL] [Abstract][Full Text] [Related]
11. O-linked mucin-type glycosylation in breast cancer. Burchell JM; Beatson R; Graham R; Taylor-Papadimitriou J; Tajadura-Ortega V Biochem Soc Trans; 2018 Aug; 46(4):779-788. PubMed ID: 29903935 [TBL] [Abstract][Full Text] [Related]
12. Differential N-Glycosylation Patterns in Lung Adenocarcinoma Tissue. Ruhaak LR; Taylor SL; Stroble C; Nguyen UT; Parker EA; Song T; Lebrilla CB; Rom WN; Pass H; Kim K; Kelly K; Miyamoto S J Proteome Res; 2015 Nov; 14(11):4538-49. PubMed ID: 26322380 [TBL] [Abstract][Full Text] [Related]
13. Functional neoglycopeptides: synthesis and characterization of a new class of MUC1 glycoprotein models having core 2-based O-glycan and complex-type N-glycan chains. Matsushita T; Sadamoto R; Ohyabu N; Nakata H; Fumoto M; Fujitani N; Takegawa Y; Sakamoto T; Kurogochi M; Hinou H; Shimizu H; Ito T; Naruchi K; Togame H; Takemoto H; Kondo H; Nishimura S Biochemistry; 2009 Nov; 48(46):11117-33. PubMed ID: 19852465 [TBL] [Abstract][Full Text] [Related]
14. beta-Elimination of O-glycans from glycoproteins transferred to immobilon P membranes: method and some applications. Duk M; Ugorski M; Lisowska E Anal Biochem; 1997 Nov; 253(1):98-102. PubMed ID: 9356147 [TBL] [Abstract][Full Text] [Related]
15. Glycosylation potential of human prostate cancer cell lines. Gao Y; Chachadi VB; Cheng PW; Brockhausen I Glycoconj J; 2012 Oct; 29(7):525-37. PubMed ID: 22843320 [TBL] [Abstract][Full Text] [Related]
16. MUC1 and cancer. Taylor-Papadimitriou J; Burchell J; Miles DW; Dalziel M Biochim Biophys Acta; 1999 Oct; 1455(2-3):301-13. PubMed ID: 10571020 [TBL] [Abstract][Full Text] [Related]
17. Novel O-linked glycans containing 6'-sulfo-Gal/GalNAc of MUC1 secreted from human breast cancer YMB-S cells: possible carbohydrate epitopes of KL-6(MUC1) monoclonal antibody. Seko A; Ohkura T; Ideo H; Yamashita K Glycobiology; 2012 Feb; 22(2):181-95. PubMed ID: 21880669 [TBL] [Abstract][Full Text] [Related]
18. Inflammatory cytokines regulate the expression of glycosyltransferases involved in the biosynthesis of tumor-associated sialylated glycans in pancreatic cancer cell lines. Bassagañas S; Allende H; Cobler L; Ortiz MR; Llop E; de Bolós C; Peracaula R Cytokine; 2015 Sep; 75(1):197-206. PubMed ID: 25934648 [TBL] [Abstract][Full Text] [Related]
19. Simple sugars to complex disease--mucin-type O-glycans in cancer. Kudelka MR; Ju T; Heimburg-Molinaro J; Cummings RD Adv Cancer Res; 2015; 126():53-135. PubMed ID: 25727146 [TBL] [Abstract][Full Text] [Related]
20. Permanent exposure of mucin-secreting HT-29 cells to benzyl-N-acetyl-alpha-D-galactosaminide induces abnormal O-glycosylation of mucins and inhibits constitutive and stimulated MUC5AC secretion. Hennebicq-Reig S; Lesuffleur T; Capon C; De Bolos C; Kim I; Moreau O; Richet C; Hémon B; Recchi MA; Maës E; Aubert JP; Real FX; Zweibaum A; Delannoy P; Degand P; Huet G Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):283-95. PubMed ID: 9693131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]